St. john's cancer institute partners with absci to expedite development of cancer therapies

Absci's generative ai and wet lab capabilities combined with st. john's cancer institute's molecular database of cancer patient specimens will accelerate the development of immunotherapies.

ABSI Ratings Summary

ABSI Quant Ranking